Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Albert, DE

Jeffrey S. Albert, Wilmington, DE US

Patent application numberDescriptionPublished
20080200504Amide Alkyl Pyridiyl Quinolines as Nk3 Receptor Modulators - Compounds of Formula (I) wherein R08-21-2008
20080214605Alkyl Sulfoxide Quinolines as Nk-3 Receptor Ligands - Compounds of Formula I09-04-2008
20080234269N-Oxo-Heterocycle and N-Oxo-Alkyl Quinoline-4-Carboxamides as Nk-3 Receptor Ligands - Compounds of Formula I09-25-2008
20080280949Oxopyridyl Quinoline Amides as Nk3 Receptor Modulators - Compounds of Formula I wherein R11-13-2008
20080287492Alkylpyridyl Quinolines as Nk3 Receptor Modulators - Compounds of Formula I11-20-2008
20080306110Alkylnitrile Quinolines as Nk-3 Receptor Ligands - Compounds of Formula I12-11-2008

Jeffrey Scott Albert, Wilmington, DE US

Patent application numberDescriptionPublished
20080287399Substituted Aminopyridines and Uses Thereof11-20-2008
20090030033Novel Compounds 894 - The invention relates to 2-aza-bicyclo[2.2.2]octane compounds and uses thereof. Particularly the invention relates to such compounds and their uses as pharmaceuticals in treating pyshoses such as schizophrenia and other diseases, disorders, or conditions.01-29-2009
20090062282Substituted Amino-Pyrimidones and Uses Thereof - This invention relates to novel compounds having the structural formula Ia or formula Ib below: (Ia, Ib), and their pharmaceutically acceptable salts, tautomers or in vivo hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of Aβ related pathologies such as cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.03-05-2009
20090221579Substituted Amino-Compounds and Uses Thereof - This invention relates to novel compounds having the structural formula Ia or formula Ib: Ia Ib and their pharmaceutically acceptable salts, tautomers or in vivo hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of Aβ related pathologies such as cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.09-03-2009

Patent applications by Jeffrey Scott Albert, Wilmington, DE US

S. Jeffrey Albert, Wilmington, DE US

Patent application numberDescriptionPublished
20080200500Quinoline Derivatives as Nk3 Antagonists - Compounds of Formula I08-21-2008